484 related articles for article (PubMed ID: 23443556)
1. De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health.
Eissing L; Scherer T; Tödter K; Knippschild U; Greve JW; Buurman WA; Pinnschmidt HO; Rensen SS; Wolf AM; Bartelt A; Heeren J; Buettner C; Scheja L
Nat Commun; 2013; 4():1528. PubMed ID: 23443556
[TBL] [Abstract][Full Text] [Related]
2. A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism.
Herman MA; Peroni OD; Villoria J; Schön MR; Abumrad NA; Blüher M; Klein S; Kahn BB
Nature; 2012 Apr; 484(7394):333-8. PubMed ID: 22466288
[TBL] [Abstract][Full Text] [Related]
3. ChREBP expression in the liver, adipose tissue and differentiated preadipocytes in human obesity.
Hurtado del Pozo C; Vesperinas-García G; Rubio MÁ; Corripio-Sánchez R; Torres-García AJ; Obregon MJ; Calvo RM
Biochim Biophys Acta; 2011 Dec; 1811(12):1194-200. PubMed ID: 21840420
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
5. The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans.
Benhamed F; Denechaud PD; Lemoine M; Robichon C; Moldes M; Bertrand-Michel J; Ratziu V; Serfaty L; Housset C; Capeau J; Girard J; Guillou H; Postic C
J Clin Invest; 2012 Jun; 122(6):2176-94. PubMed ID: 22546860
[TBL] [Abstract][Full Text] [Related]
6. CB1 blockade potentiates down-regulation of lipogenic gene expression in perirenal adipose tissue in high carbohydrate diet-induced obesity.
Vida M; Rivera P; Gavito AL; Suárez J; Pavón FJ; Arrabal S; Romero-Cuevas M; Bautista D; Martínez A; de Fonseca FR; Serrano A; Baixeras E
PLoS One; 2014; 9(2):e90016. PubMed ID: 24587189
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue mTORC2 regulates ChREBP-driven de novo lipogenesis and hepatic glucose metabolism.
Tang Y; Wallace M; Sanchez-Gurmaches J; Hsiao WY; Li H; Lee PL; Vernia S; Metallo CM; Guertin DA
Nat Commun; 2016 Apr; 7():11365. PubMed ID: 27098609
[TBL] [Abstract][Full Text] [Related]
8. Acetyl-CoA carboxylase 2-/- mutant mice are protected against fatty liver under high-fat, high-carbohydrate dietary and de novo lipogenic conditions.
Abu-Elheiga L; Wu H; Gu Z; Bressler R; Wakil SJ
J Biol Chem; 2012 Apr; 287(15):12578-88. PubMed ID: 22362781
[TBL] [Abstract][Full Text] [Related]
9. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
10. ChREBP regulates fructose-induced glucose production independently of insulin signaling.
Kim MS; Krawczyk SA; Doridot L; Fowler AJ; Wang JX; Trauger SA; Noh HL; Kang HJ; Meissen JK; Blatnik M; Kim JK; Lai M; Herman MA
J Clin Invest; 2016 Nov; 126(11):4372-4386. PubMed ID: 27669460
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP.
Xu X; So JS; Park JG; Lee AH
Semin Liver Dis; 2013 Nov; 33(4):301-11. PubMed ID: 24222088
[TBL] [Abstract][Full Text] [Related]
12. Decreased transcription of ChREBP-α/β isoforms in abdominal subcutaneous adipose tissue of obese adolescents with prediabetes or early type 2 diabetes: associations with insulin resistance and hyperglycemia.
Kursawe R; Caprio S; Giannini C; Narayan D; Lin A; D'Adamo E; Shaw M; Pierpont B; Cushman SW; Shulman GI
Diabetes; 2013 Mar; 62(3):837-44. PubMed ID: 23209190
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of de Novo Fatty Acid Synthesis in Subcutaneous Adipose Tissue of Moderately Obese Women.
Guiu-Jurado E; Auguet T; Berlanga A; Aragonès G; Aguilar C; Sabench F; Armengol S; Porras JA; Martí A; Jorba R; Hernández M; del Castillo D; Richart C
Int J Mol Sci; 2015 Dec; 16(12):29911-22. PubMed ID: 26694359
[TBL] [Abstract][Full Text] [Related]
14. ChREBP binding and histone modifications modulate hepatic expression of the Fasn gene in a metabolic syndrome rat model.
Suzuki T; Muramatsu T; Morioka K; Goda T; Mochizuki K
Nutrition; 2015 Jun; 31(6):877-83. PubMed ID: 25933497
[TBL] [Abstract][Full Text] [Related]
15. Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.
Smith U; Kahn BB
J Intern Med; 2016 Nov; 280(5):465-475. PubMed ID: 27699898
[TBL] [Abstract][Full Text] [Related]
16. De novo lipogenesis in adipose tissue is associated with course of morbid obesity after bariatric surgery.
Garrido-Sánchez L; Vendrell J; Fernández-García D; Ceperuelo-Mallafré V; Chacón MR; Ocaña-Wilhelmi L; Alcaide J; Tinahones FJ; García-Fuentes E
PLoS One; 2012; 7(2):e31280. PubMed ID: 22384010
[TBL] [Abstract][Full Text] [Related]
17. Fructose containing sugars modulate mRNA of lipogenic genes ACC and FAS and protein levels of transcription factors ChREBP and SREBP1c with no effect on body weight or liver fat.
Janevski M; Ratnayake S; Siljanovski S; McGlynn MA; Cameron-Smith D; Lewandowski P
Food Funct; 2012 Feb; 3(2):141-9. PubMed ID: 22159273
[TBL] [Abstract][Full Text] [Related]
18. Hepatic Carbohydrate Response Element Binding Protein Activation Limits Nonalcoholic Fatty Liver Disease Development in a Mouse Model for Glycogen Storage Disease Type 1a.
Lei Y; Hoogerland JA; Bloks VW; Bos T; Bleeker A; Wolters H; Wolters JC; Hijmans BS; van Dijk TH; Thomas R; van Weeghel M; Mithieux G; Houtkooper RH; de Bruin A; Rajas F; Kuipers F; Oosterveer MH
Hepatology; 2020 Nov; 72(5):1638-1653. PubMed ID: 32083759
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
20. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
